NDC Active Ingredient Ranibizumab
Active Ingredient Information
What is Ranibizumab?
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
What is the usage for Ranibizumab?
This medication is used to treat certain serious eye conditions (such as age-related macular degeneration, macular edema, diabetic retinopathy). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.
How many products in the NDC database contain Ranibizumab?
The NDC database has 13 products with the active ingredient Ranibizumab. The following table lists all the products that have this active ingredient.
NDC Products with Ranibizumab
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
50242-078 | Proprietary Name: Susvimo | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | |
50242-080 | Proprietary Name: Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | |
50242-082 | Proprietary Name: Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | |
50242-183 | Proprietary Name: | Ranibizumab | Solution | Genentech, Inc. | ACTIVE | ||
64406-019 | Proprietary Name: Byooviz | Ranibizumab-nuna | Injection, Solution | Intravitreal | Biogen Inc. | ACTIVE | |
68225-123 | Proprietary Name: | Ranibizumab | Injection, Solution | Patheon Italia S.p.a. | ACTIVE | ||
70114-440 | Proprietary Name: Cimerli | Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE | |
70114-441 | Proprietary Name: Cimerli | Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE | |
71082-110 | Proprietary Name: | Ranibizumab | Injection, Solution | Frueh Verpackungstechnik Ag | ACTIVE | ||
71082-111 | Proprietary Name: | Ranibizumab | Injection, Solution | Frueh Verpackungstechnik Ag | ACTIVE | ||
82775-100 | Proprietary Name: | Ranibizumab | Solution, Concentrate | Polpharma Biologics Sa | ACTIVE | ||
83832-110 | Proprietary Name: | Ranibizumab | Injection, Solution | Labor Zollinger Ag | ACTIVE | ||
83832-111 | Proprietary Name: | Ranibizumab | Injection, Solution | Labor Zollinger Ag | ACTIVE |